{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:24:00Z","timestamp":1787027040102,"version":"build-2736575974"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Tumor draining lymph nodes (TDLNs), as secondary lymphoid organs, are pivotal in initiating and regulating adaptive immune responses. Historically, TDLNs were recognized primarily as metastasis gateways in cancer, promoting radical dissection to prevent recurrence. However, emerging preclinical studies reveals their critical role in orchestrating systemic anti-tumor immune responses during cancer therapy, highlighting the dilemma of balancing lymph nodes (LNs) preservation with metastasis control. This review traces the evolving understanding of TDLN biology in oncology, from the era of radical LN dissection to multi-omics-driven insights, and synthesizes their dual roles as immune hubs and metastatic niches across first-line clinical therapies (e.g., immunotherapy, radiotherapy, chemotherapy, targeted therapy, etc.). We further propose the concept of \u201cLymph Node Multi-modal Protective Research (LNMPR)\u201d, emphasizing the prospective value of integrating multi-omics technologies, including spatial transcriptomics, single-cell profiling, and imaging, to decode LN immune dynamics and optimize therapeutic responses. By bridging mechanistic insights with clinical strategies, LN-centric immune modulation may open up a new path for precise tumor treatment.<\/jats:p>","DOI":"10.3389\/fonc.2025.1636942","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T10:55:34Z","timestamp":1755600934000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["From trash to treasure: tumor draining lymph nodes as a multi-omics goldmine in cancer therapy"],"prefix":"10.3389","volume":"15","author":[{"given":"Yina","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangnan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.semcdb.2015.01.008","article-title":"The lymph node microenvironment and its role in the progression of metastatic cancer","volume":"38","author":"Pereira","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000658-190707000-00001","article-title":"I. The results of radical operations for the cure of carcinoma of the breast","volume":"46","author":"Halsted","year":"1907","journal-title":"Ann Surg"},{"key":"B3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1126\/science.aai8515","article-title":"Origins of lymphatic and distant metastases in human colorectal cancer","volume":"357","author":"Naxerova","year":"2017","journal-title":"Science"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102793","article-title":"Phylogenetic reconstruction of breast cancer reveals two routes of metastatic dissemination associated with distinct clinical outcome","volume":"56","author":"Venet","year":"2020","journal-title":"EBioMedicine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s40425-019-0605-1","article-title":"Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node","volume":"7","author":"Van Pul","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2023.04.001","article-title":"Lymph nodes: at the intersection of cancer treatment and progression","volume":"33","author":"Reticker-Flynn","year":"2023","journal-title":"Trends Cell Biol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"B10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.immuni.2022.12.002","article-title":"CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor","volume":"56","author":"Prokhnevska","year":"2023","journal-title":"Immunity"},{"key":"B11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12929-022-00868-1","article-title":"Reprogramming of sentinel lymph node microenvironment during tumor metastasis","volume":"29","author":"Li","year":"2022","journal-title":"J BioMed Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1148\/radiol.2019190014","article-title":"Predicting axillary response to neoadjuvant chemotherapy: breast MRI and US in patients with node-positive breast cancer","volume":"293","author":"Kim","year":"2019","journal-title":"Radiology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.21037\/atm-2022-21","article-title":"Is it time to retire sentinel lymph node biopsy and use multi-omics prediction models","volume":"10","author":"Kieran","year":"2022","journal-title":"Ann Transl Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.cell.2023.02.021","article-title":"Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes","volume":"186","author":"Rahim","year":"2023","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.100977","article-title":"Multiplex imaging of breast cancer lymph node metastases identifies prognostic single-cell populations independent of clinical classifiers","volume":"4","author":"Fischer","year":"2023","journal-title":"Cell Rep Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer","volume":"21","author":"Hiam-Galvez","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2025.04.008","article-title":"Tumor-draining lymph nodes \u2013 friend or foe during immune checkpoint therapy","author":"Von Renesse","year":"2025","journal-title":"Trends Cancer"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.1038\/s41467-022-34581-2","article-title":"Single cell profiling of primary and paired metastatic lymph node tumors in breast cancer patients","volume":"13","author":"Liu","year":"2022","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400524","article-title":"SPP1+ TAM regulates the metastatic colonization of CXCR4+ Metastasis-associated tumor cells by remodeling the lymph node microenvironment","volume":"11","author":"Dong","year":"2024","journal-title":"Adv Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav0173","article-title":"Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation","volume":"363","author":"Lee","year":"2019","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.34133\/research.0346","article-title":"B cells and IL-21-producing follicular helper T cells cooperate to determine the dynamic alterations of premetastatic tumor draining lymph nodes of breast cancer","volume":"7","author":"Mao","year":"2024","journal-title":"Res Wash DC"},{"key":"B22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40164-023-00407-0","article-title":"ScRNA-seq revealed an immunosuppression state and tumor microenvironment heterogeneity related to lymph node metastasis in prostate cancer","volume":"12","author":"Xin","year":"2023","journal-title":"Exp Hematol Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41698-024-00639-1","article-title":"Prognostic patterns in invasion lymph nodes of lung adenocarcinoma reveal distinct tumor microenvironments","volume":"8","author":"Lao","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3492","article-title":"Tumor-induced stromal reprogramming drives lymph node transformation","volume":"17","author":"Riedel","year":"2016","journal-title":"Nat Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20111627","article-title":"Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses","volume":"210","author":"Das","year":"2013","journal-title":"J Exp Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04758-2","article-title":"PHGDH heterogeneity potentiates cancer cell dissemination and metastasis","volume":"605","author":"Rossi","year":"2022","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0309-y","article-title":"Tumor-educated B cells selectively promote breast cancer lymph node metastasis by HSPA4-targeting IgG","volume":"25","author":"Gu","year":"2019","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239","article-title":"Combination immunotherapy with 4-1BB activation and PD-1 blockade enhances antitumor efficacy in a mouse model of subcutaneous tumor","volume":"35","author":"Shindo","year":"2015","journal-title":"Anticancer Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nri3405","article-title":"Molecular mechanisms of T cell co-stimulation and co-inhibition","volume":"13","author":"Chen","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/imr.12799","article-title":"Role of lymph node stroma and microenvironment in T cell tolerance","volume":"292","author":"Saxena","year":"2019","journal-title":"Immunol Rev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12967-014-0373-0","article-title":"PD-1\/PD-L1 pathway in non-small-cell lung cancer and its relation with EGFR mutation","volume":"13","author":"Ji","year":"2015","journal-title":"J Transl Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000515","article-title":"Prognostic significance of programmed cell death 1 (PD-1) or PD-1 ligand 1 (PD-L1) Expression in epithelial-originated cancer: a meta-analysis","volume":"94","author":"Zhang","year":"2015","journal-title":"Med (Baltimore)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/8.5.765","article-title":"Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes","volume":"8","author":"Agata","year":"1996","journal-title":"Int Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2014.11.014","article-title":"Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma","volume":"51","author":"Ritprajak","year":"2015","journal-title":"Oral Oncol"},{"key":"B39","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He","year":"","journal-title":"Cell Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.0105","article-title":"Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab","volume":"32","author":"Topalian","year":"2014","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01497","article-title":"First-line immunotherapy for non-small-cell lung cancer","volume":"40","author":"Reck","year":"2022","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916623","article-title":"The effect of advances in lung-cancer treatment on population mortality","volume":"383","author":"Howlader","year":"2020","journal-title":"N Engl J Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.0703","article-title":"Nivolumab for metastatic renal cell carcinoma: results of a randomized phase II trial","volume":"33","author":"Motzer","year":"2015","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00236","article-title":"Standard versus modified ipilimumab, in combination with nivolumab, in advanced renal cell carcinoma: A randomized phase II trial (PRISM)","volume":"42","author":"Vasudev","year":"2024","journal-title":"J Clin Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12943-023-01850-7","article-title":"Advances in immunotherapy for triple-negative breast cancer","volume":"22","author":"Liu","year":"2023","journal-title":"Mol Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/annonc\/mdy517","article-title":"Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study","volume":"30","author":"Adams","year":"2019","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.06.003","article-title":"Critical role for CD103(+)\/CD141(+) dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma","volume":"30","author":"Roberts","year":"2016","journal-title":"Cancer Cell"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.03.039","article-title":"Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma","volume":"77","author":"Chuah","year":"2022","journal-title":"J Hepatol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.immuni.2018.09.024","article-title":"Successful anti-PD-1 cancer immunotherapy requires T cell-dendritic cell crosstalk involving the cytokines IFN-\u03b3 and IL-12","volume":"49","author":"Garris","year":"2018","journal-title":"Immunity"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.ccell.2023.06.008","article-title":"A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity","volume":"41","author":"Meiser","year":"2023","journal-title":"Cancer Cell"},{"key":"B53","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.immuni.2021.10.020","article-title":"Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity","volume":"55","author":"Duong","year":"2022","journal-title":"Immunity"},{"key":"B54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.immuni.2010.12.011","article-title":"CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens","volume":"34","author":"Asano","year":"2011","journal-title":"Immunity"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101420","article-title":"PD-L1-expressing tumor-associated macrophages are immunostimulatory and associate with good clinical outcome in human breast cancer","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","article-title":"Regulatory mechanisms of PD-1\/PD-L1 in cancers","volume":"23","author":"Lin","year":"2024","journal-title":"Mol Cancer"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity cycle: Indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abg7836","article-title":"A reservoir of stem-like CD8+ T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response","volume":"6","author":"Connolly","year":"2021","journal-title":"Sci Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1016\/j.cell.2022.09.020","article-title":"The primordial differentiation of tumor-specific memory CD8+ T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes","volume":"185","author":"Huang","year":"2022","journal-title":"Cell"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00521-2","article-title":"CD4+ T cells in cancer","volume":"4","author":"Speiser","year":"2023","journal-title":"Nat Cancer"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2611-3","article-title":"cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity","volume":"584","author":"Ferris","year":"2020","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2024.07.009","article-title":"CD4+ T cells in antitumor immunity","volume":"10","author":"Montauti","year":"2024","journal-title":"Trends Cancer"},{"key":"B63","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/imr.12860","article-title":"T follicular helper cells in germinal center B cell selection and lymphomagenesis","volume":"296","author":"Mintz","year":"2020","journal-title":"Immunol Rev"},{"key":"B64","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.trecan.2023.09.006","article-title":"The tumor-draining lymph node as a reservoir for systemic immune surveillance","volume":"10","author":"Delclaux","year":"2024","journal-title":"Trends Cancer"},{"key":"B65","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1038\/s41467-020-17046-2","article-title":"Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients","volume":"11","author":"N\u00fa\u00f1ez","year":"2020","journal-title":"Nat Commun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay3575","article-title":"Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy","volume":"12","author":"Francis","year":"2020","journal-title":"Sci Transl Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1016\/j.cell.2022.04.019","article-title":"Lymph node colonization induces tumor-immune tolerance to promote distant metastasis","volume":"185","author":"Reticker-Flynn","year":"2022","journal-title":"Cell"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.cell.2019.10.028","article-title":"B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer","volume":"179","author":"Hollern","year":"2019","journal-title":"Cell"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/s12274-021-4015-6","article-title":"Surface hydrophobic modification enhanced catalytic performance of electrochemical nitrogen reduction reaction","volume":"15","author":"Niu","year":"2022","journal-title":"Nano Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06231-0","article-title":"B-cell-specific checkpoint molecules that regulate anti-tumour immunity","volume":"619","author":"Bod","year":"2023","journal-title":"Nature"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1126\/science.abg2752","article-title":"CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses","volume":"379","author":"He","year":"2023","journal-title":"Science"},{"key":"B72","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T cell states associated with response to checkpoint immunotherapy in melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/j.immuni.2021.08.019","article-title":"Resident memory CD8+ T cells in regional lymph nodes mediate immunity to metastatic melanoma","volume":"54","author":"Molodtsov","year":"2021","journal-title":"Immunity"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2134-y","article-title":"A conserved dendritic-cell regulatory program limits antitumour immunity","volume":"580","author":"Maier","year":"2020","journal-title":"Nature"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2016.09.007","article-title":"Immune priming of the tumor microenvironment by radiation","volume":"2","author":"Jiang","year":"2016","journal-title":"Trends Cancer"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.5.3132","article-title":"Radiation-induced IFN-\u03b3 Production within the tumor microenvironment influences antitumor immunity1","volume":"180","author":"Lugade","year":"2008","journal-title":"J Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2011.29","article-title":"Optimizing DC vaccination by combination with oncolytic adenovirus coexpressing IL-12 and GM-CSF","volume":"19","author":"Zhang","year":"2011","journal-title":"Mol Ther"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2014.44","article-title":"Double-stranded DNA in exosomes: a novel biomarker in cancer detection","volume":"24","author":"Thakur","year":"2014","journal-title":"Cell Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1269166","article-title":"Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancer","volume":"13","author":"Khalifa","year":"2023","journal-title":"Front Oncol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1200\/JCO.2004.08.021","article-title":"Final results of the 94\u201301 french head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma","volume":"22","author":"Denis","year":"2004","journal-title":"J Clin Oncol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"N Engl J Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.211","article-title":"Radiotherapy and immunotherapy: a beneficial liaison","volume":"14","author":"Weichselbaum","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-023-01093-8","article-title":"Chemotherapy-induced metastasis: molecular mechanisms and clinical therapies","volume":"44","author":"Su","year":"2023","journal-title":"Acta Pharmacol Sin"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2023","journal-title":"Genes Dis"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J Pharm Pharmacol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e14-04-0916","article-title":"How Taxol\/paclitaxel kills cancer cells","volume":"25","author":"Weaver","year":"2014","journal-title":"Mol Biol Cell"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abg3551","article-title":"Tumor-draining lymph nodes: At the crossroads of metastasis and immunity","volume":"6","author":"Du Bois","year":"2021","journal-title":"Sci Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.88","article-title":"Monitoring immune-checkpoint blockade: response evaluation and biomarker development","volume":"14","author":"Nishino","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01286-8","article-title":"Genomic and transcriptomic analysis of breast cancer identifies novel signatures associated with response to neoadjuvant chemotherapy","volume":"16","author":"Yin","year":"2024","journal-title":"Genome Med"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e1331807","DOI":"10.1080\/2162402X.2017.1331807","article-title":"Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells","volume":"6","author":"Wang","year":"2017","journal-title":"Oncoimmunology"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-015-0669-x","article-title":"Lymphocyte depletion and repopulation after chemotherapy for primary breast cancer","volume":"18","author":"Verma","year":"2016","journal-title":"Breast Cancer Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bioactmat.2021.12.020","article-title":"Mature dendritic cell-derived dendrosomes swallow oxaliplatin-loaded nanoparticles to boost immunogenic chemotherapy and tumor antigen-specific immunotherapy","volume":"15","author":"Chen","year":"2022","journal-title":"Bioact Mater"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12574","article-title":"Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses","volume":"280","author":"Garg","year":"2017","journal-title":"Immunol Rev"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.07.013","article-title":"Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy","volume":"129","author":"Zhang","year":"2008","journal-title":"Clin Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0064","article-title":"The interplay of immunotherapy and chemotherapy: harnessing potential synergies","volume":"3","author":"Emens","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809615","article-title":"Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer","volume":"379","author":"Schmid","year":"2018","journal-title":"N Engl J Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S1470-2045(18)30111-6","article-title":"Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial","volume":"19","author":"Loibl","year":"2018","journal-title":"Lancet Oncol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61964-4","article-title":"Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort","volume":"375","author":"Gianni","year":"2010","journal-title":"Lancet"},{"key":"B101","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nri2216","article-title":"Immunological aspects of cancer chemotherapy","volume":"8","author":"Zitvogel","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41523-018-0081-7","article-title":"Sentinel lymph node B cells can predict disease-free survival in breast cancer patients","volume":"4","author":"Blenman","year":"2018","journal-title":"NPJ Breast Cancer"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103542","article-title":"Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours","volume":"71","author":"Chen","year":"2021","journal-title":"eBioMedicine"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3455","article-title":"Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases","volume":"10","author":"Carmeliet","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209124","article-title":"Trastuzumab emtansine for HER2-positive advanced breast cancer","volume":"367","author":"Verma","year":"2012","journal-title":"N Engl J Med"},{"key":"B106","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ccell.2020.09.001","article-title":"The PD-1\/PD-L1-checkpoint restrains T cell immunity in tumor-draining lymph nodes","volume":"38","author":"Dammeijer","year":"2020","journal-title":"Cancer Cell"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.674558","article-title":"Lymph node immune profiles as predictive biomarkers for immune checkpoint inhibitor response","volume":"8","author":"Goode","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2023.02.010","article-title":"Selective mediastinal lymph node dissection strategy for clinical T1N0 invasive lung cancer: A prospective, multicenter, clinical trial","volume":"18","author":"Zhang","year":"2023","journal-title":"J Thorac Oncol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-1789","article-title":"Sensitive MRD detection from lymphatic fluid after surgery in HPV-associated oropharyngeal cancer","volume":"30","author":"Earland","year":"2024","journal-title":"Clin Cancer Res"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-024-02576-0","article-title":"Multiplexed spatial mapping of chromatin features, transcriptome and proteins in tissues","volume":"22","author":"Guo","year":"2025","journal-title":"Nat Methods"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124507","article-title":"Tumor-draining lymph nodes are pivotal in PD-1\/PD-L1 checkpoint therapy","volume":"3","author":"Fransen","year":"2018","journal-title":"JCI Insight"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1636942\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T10:55:35Z","timestamp":1755600935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1636942\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":111,"alternative-id":["10.3389\/fonc.2025.1636942"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1636942","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"article-number":"1636942"}}